VDAA
Latest Information Update: 14 Apr 2023
At a glance
- Originator Veradermics
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Alopecia areata
Most Recent Events
- 14 Apr 2023 Preclinical trials in Alopecia areata in USA (Topical), prior to April 2023 (Veradermics pipeline, April 2023)